ICX-RHY is likely coming to a cosmetic surgeon near you -- if you live in the United Kingdom. Phase 1 trials to test safety and tolerability ended successfully last year, and the company is expecting to begin a Phase II trial soon. Phase II will test the efficacy of ICX-RHY.
Fibroblasts, up close and personal
ICX-RHY is an injectable treatment for wrinkles. What makes it different is that the injected cells, fibroblasts, go on to promote regeneration of new collagen. The treatments are believed to last up to several years, rather than the few months that current injectable treatments last.
Additionally, rather than achieving an immediate and, perhaps surprisingly, plumped up appearance, ICX-RHY injections result in a gradual increase in rejuvenated skin.
Depending on how upcoming trials end, Intercytex, makers of ICX-RHY, hope to have it on the UK market by late 2007.
Find out more about ICX-RHY in this downloadable PDF product sheet on the Intercytex website.